Enjoy complimentary customisation on priority with our Enterprise License!
The mycoplasma testing market size is estimated to grow by USD 743.4 million, at a CAGR of 12.68% between 2023 and 2028. There is increasing adoption of real-time mycoplasma testing across the hospital sectors. One of the main advantages of real-time mycoplasma testing is that it quickly offers the presence of mycoplasma contamination in biological products, unlike traditional testing which requires days or months to deliver the mycoplasma test results. Additionally, there is an increasing focus on the development of real-time mycoplasma testing products and other medical technologies. There is an increasing demand for these systems in pharmaceutical and biotechnology companies, stem cell banks, academic research institutes, and CROs due to their ability to quickly identify mycoplasma within a few hours. Furthermore, there is a growing popularity for real-time mycoplasma testing products in cell line development, cell banks, and harvest media, which is expected to positively impact market growth.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.